Carbone, E.A.; Caroleo, M.; Rania, M.; de Filippis, R.; Condoleo, F.; Catalano, F.; Aloi, M.; De Fazio, P.; Arturi, F.; Hribal, M.L.;
et al. Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity. Biomedicines 2024, 12, 451.
https://doi.org/10.3390/biomedicines12020451
AMA Style
Carbone EA, Caroleo M, Rania M, de Filippis R, Condoleo F, Catalano F, Aloi M, De Fazio P, Arturi F, Hribal ML,
et al. Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity. Biomedicines. 2024; 12(2):451.
https://doi.org/10.3390/biomedicines12020451
Chicago/Turabian Style
Carbone, Elvira Anna, Mariarita Caroleo, Marianna Rania, Renato de Filippis, Francesca Condoleo, Federica Catalano, Matteo Aloi, Pasquale De Fazio, Franco Arturi, Marta Letizia Hribal,
and et al. 2024. "Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity" Biomedicines 12, no. 2: 451.
https://doi.org/10.3390/biomedicines12020451
APA Style
Carbone, E. A., Caroleo, M., Rania, M., de Filippis, R., Condoleo, F., Catalano, F., Aloi, M., De Fazio, P., Arturi, F., Hribal, M. L., Fiorentino, T. V., & Segura-Garcia, C.
(2024). Influence of NUCB/Nesfatin-1 Polymorphism on Treatment Response to Naltrexone/Bupropion SR in Binge Eating Disorder and Obesity. Biomedicines, 12(2), 451.
https://doi.org/10.3390/biomedicines12020451